Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M – MedCity News,

Bayer advanced the BlueRock Parkinson’s cell therapy into human testing last summer, a Phase 1 clinical trial enrolling about a dozen patients., Bayer advanced the BlueRock Parkinson’s cell therapy into human testing last summer, a Phase 1 clinical trial enrolling about a dozen patients., Read More

Scroll to Top